246 related articles for article (PubMed ID: 12115398)
1. Familial breast carcinoma risks by morphology: a nationwide epidemiologic study from Sweden.
Hemminki K; Granström C
Cancer; 2002 Jun; 94(11):3063-70. PubMed ID: 12115398
[TBL] [Abstract][Full Text] [Related]
2. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
Ji J; Hemminki K
Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
[TBL] [Abstract][Full Text] [Related]
3. Familial and second gastric carcinomas: a nationwide epidemiologic study from Sweden.
Hemminki K; Jiang Y
Cancer; 2002 Feb; 94(4):1157-65. PubMed ID: 11920487
[TBL] [Abstract][Full Text] [Related]
4. Familial breast cancer: scope for more susceptibility genes?
Hemminki K; Granström C
Breast Cancer Res Treat; 2003 Nov; 82(1):17-22. PubMed ID: 14672399
[TBL] [Abstract][Full Text] [Related]
5. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
7. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
Aulmann S; Penzel R; Schirmacher P; Sinn HP
Verh Dtsch Ges Pathol; 2007; 91():208-13. PubMed ID: 18314616
[TBL] [Abstract][Full Text] [Related]
8. Attributable risks for familial breast cancer by proband status and morphology: a nationwide epidemiologic study from Sweden.
Hemminki K; Granström C; Czene K
Int J Cancer; 2002 Jul; 100(2):214-9. PubMed ID: 12115572
[TBL] [Abstract][Full Text] [Related]
9. Age specific and attributable risks of familial prostate carcinoma from the family-cancer database.
Hemminki K; Czene K
Cancer; 2002 Sep; 95(6):1346-53. PubMed ID: 12216104
[TBL] [Abstract][Full Text] [Related]
10. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB
Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499
[TBL] [Abstract][Full Text] [Related]
11. Familial risk of cancer shortly after diagnosis of the first familial tumor.
Bermejo JL; Hemminki K
J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in Sweden.
Wärnberg F; Bergh J; Zack M; Holmberg L
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):495-9. PubMed ID: 11352860
[TBL] [Abstract][Full Text] [Related]
13. Changing incidence rate of invasive lobular breast carcinoma among older women.
Li CI; Anderson BO; Porter P; Holt SK; Daling JR; Moe RE
Cancer; 2000 Jun; 88(11):2561-9. PubMed ID: 10861434
[TBL] [Abstract][Full Text] [Related]
14. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
[TBL] [Abstract][Full Text] [Related]
15. Morphological types of breast cancer in family members and multiple primary tumours: is morphology genetically determined?
Hemminki K; Granström C
Breast Cancer Res; 2002; 4(4):R7. PubMed ID: 12100745
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological survey of preinvasive breast cancer.
Vandenbroucke A; Bourdon C
Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():3-10. PubMed ID: 8298449
[TBL] [Abstract][Full Text] [Related]
17. Timing of familial breast cancer in sisters.
Rebora P; Czene K; Reilly M
J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
[TBL] [Abstract][Full Text] [Related]
18. High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.
Shahedi K; Emanuelsson M; Wiklund F; Gronberg H
Cancer; 2006 Mar; 106(6):1237-42. PubMed ID: 16475207
[TBL] [Abstract][Full Text] [Related]
19. Time trends and familial risks in squamous cell carcinoma of the skin.
Hemminki K; Zhang H; Czene K
Arch Dermatol; 2003 Jul; 139(7):885-9. PubMed ID: 12873883
[TBL] [Abstract][Full Text] [Related]
20. Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas.
Aldaz CM; Chen T; Sahin A; Cunningham J; Bondy M
Cancer Res; 1995 Sep; 55(18):3976-81. PubMed ID: 7664266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
